BPC-157 Peptide Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a naturally occurring protein fragment found in human gastric juice. It consists of 15 amino acids and has demonstrated remarkable stability in biological environments. BPC-157 has been extensively studied in preclinical research for its protective and regenerative effects across multiple tissue systems, particularly in models of soft tissue injury, gastrointestinal damage, and vascular dysfunction.

Tissue Repair and Regenerative Effects of BPC-157

Accelerates Soft Tissue Healing

BPC-157 has been shown to significantly enhance the healing of tendons, ligaments, muscles, and skin in animal models. It promotes fibroblast activity, supports collagen organization, and improves structural integrity at injury sites. These effects have been observed even in compromised healing conditions, including corticosteroid exposure and poor circulation.

Supported by:
Staresinic et al., Journal of Orthopaedic Research; Seiwerth et al., Current Pharmaceutical Design

Enhances Angiogenesis and Blood Vessel Integrity

Proper blood flow is essential for tissue repair. BPC-157 has been shown to promote angiogenesis and stabilize existing blood vessels, improving perfusion to injured tissue. Research demonstrates that it can rapidly restore vascular function following trauma, ischemia, or chemical injury, supporting faster and more complete recovery.

Supported by:
Sikiric et al., Journal of Physiology and Pharmacology; Cesarec et al., Microvascular Research

Gastrointestinal Protective Properties

Protects and Repairs the Gastrointestinal Tract

BPC-157 was originally studied for its potent protective effects on the gastrointestinal system. Research shows it can prevent and heal damage to the stomach and intestines caused by NSAIDs, alcohol, stress, and inflammatory conditions. It supports mucosal integrity, enhances epithelial repair, and reduces inflammation throughout the GI tract.

Supported by:
Sikiric et al., Alimentary Pharmacology & Therapeutics; Seiwerth et al., Journal of Physiology-Paris

Supports Gut-Brain Axis Stability

Preclinical studies suggest BPC-157 may influence the gut-brain axis by stabilizing neurotransmitter systems and reducing inflammation. These effects may contribute to its observed protective actions in models of stress, anxiety-like behavior, and central nervous system injury.

Supported by:
Sikiric et al., Neuropharmacology; Vlainic et al., Behavioural Brain Research

Anti-Inflammatory and Cytoprotective Effects

BPC-157 exhibits strong anti-inflammatory activity by modulating nitric oxide pathways, reducing oxidative stress, and stabilizing cellular membranes. Unlike traditional anti-inflammatory agents, BPC-157 does not inhibit cyclooxygenase pathways, allowing it to reduce inflammation without impairing normal healing processes.

Supported by:
Sikiric et al., Inflammopharmacology; Seiwerth et al., Current Pharmaceutical Design

Neuroprotective and Systemic Protective Potential

BPC-157 has demonstrated neuroprotective effects in experimental models of brain and spinal cord injury. Studies show reduced neuronal damage, improved functional recovery, and stabilization of dopaminergic and serotonergic systems. Additional research suggests systemic protective effects across cardiovascular, hepatic, and renal models of injury.

Supported by:
Vlainic et al., Neuropharmacology; Sikiric et al., Medical Hypotheses

BPC-157 Peptide Specifications

• CAS Number: 137525-51-0

• Molecular Formula: C₆₂H₉₈N₁₆O₂₂

• Molecular Weight: 1419.5 g/mol

• Peptide Class: Pentadecapeptide (15 amino acids)

• Form: Lyophilized powder in sterile glass vial

• Purity: ≥98%

• Quantity: Commonly supplied as 5 mg or 10 mg per vial

• Color: White to off-white powder

• Storage: Refrigerate after reconstitution

Important Notice

This compound is intended strictly for in vitro laboratory research conducted by qualified professionals. BPC-157 is not approved by the U.S. Food and Drug Administration (FDA) for human or veterinary use and must not be marketed, labeled, or represented as a drug, dietary supplement, cosmetic, or food product.

References

1. Sikiric P et al. Stable gastric pentadecapeptide BPC-157: novel therapy in gastrointestinal and extra-intestinal disorders. Alimentary Pharmacology & Therapeutics.
   https://pubmed.ncbi.nlm.nih.gov/11207720/

2. Seiwerth S et al. BPC-157 and wound healing: experimental and clinical evidence. Current Pharmaceutical Design.
   https://pubmed.ncbi.nlm.nih.gov/20491627/

3. Staresinic M et al. BPC-157 improves tendon healing and ligament regeneration. Journal of Orthopaedic Research.
   https://pubmed.ncbi.nlm.nih.gov/18566906/

4. Cesarec V et al. BPC-157 improves angiogenesis and vascular recovery. Microvascular Research.
   https://pubmed.ncbi.nlm.nih.gov/24486625/

5. Vlainic J et al. BPC-157 neuroprotective effects in central nervous system injury models. Neuropharmacology.
   https://pubmed.ncbi.nlm.nih.gov/23911976/

6. Sikiric P et al. Nitric oxide system modulation by BPC-157. Journal of Physiology and Pharmacology.
   https://pubmed.ncbi.nlm.nih.gov/16227745/

7. Seiwerth S et al. Cytoprotection and anti-inflammatory effects of BPC-157. Inflammopharmacology.
   https://pubmed.ncbi.nlm.nih.gov/20112070/

8. Vlainic J et al. BPC-157 and the gut-brain axis. Behavioural Brain Research.
   https://pubmed.ncbi.nlm.nih.gov/27157665/

Complete Disclaimer

This product is sold exclusively for laboratory research purposes under Section 351 of the Public Health Service Act. It is not intended for human or veterinary use, nor for diagnostic, therapeutic, or cosmetic applications. Purchaser certifies they are properly licensed and equipped to handle research compounds in compliance with all local, state, and federal regulations. Eaglepeptidesusa.com assumes no liability for misuse or unauthorized handling. By purchasing, you affirm this material will not be introduced into interstate commerce or used in food/drug products.